Ionis Pharmaceuticals, Inc. (IONS) DCF Valuation

Ionis Pharmaceuticals, Inc. (IONS) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Ionis Pharmaceuticals, Inc. (IONS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you’re an investor or an analyst, this [IONS] DCF Calculator is your go-to resource for accurate valuation. Equipped with Ionis Pharmaceuticals, Inc. real data, you can adjust forecasts and observe the effects in real-time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 1,123.0 729.0 810.0 587.0 787.6 753.5 720.9 689.7 659.8 631.2
Revenue Growth, % 0 -35.08 11.11 -27.53 34.18 -4.33 -4.33 -4.33 -4.33 -4.33
EBITDA 411.5 -107.9 -.2 -227.8 -230.0 -69.6 -66.6 -63.7 -60.9 -58.3
EBITDA, % 36.65 -14.8 -0.02950617 -38.8 -29.2 -9.24 -9.24 -9.24 -9.24 -9.24
Depreciation 16.0 17.2 19.6 22.1 22.5 19.3 18.5 17.7 16.9 16.2
Depreciation, % 1.42 2.35 2.41 3.77 2.86 2.56 2.56 2.56 2.56 2.56
EBIT 395.5 -125.0 -19.8 -249.9 -252.5 -88.9 -85.1 -81.4 -77.9 -74.5
EBIT, % 35.22 -17.15 -2.44 -42.57 -32.06 -11.8 -11.8 -11.8 -11.8 -11.8
Total Cash 2,500.0 1,892.0 2,115.0 1,987.0 2,331.2 753.5 720.9 689.7 659.8 631.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 63.0 76.2 61.9 25.5 97.8
Account Receivables, % 5.61 10.45 7.64 4.35 12.41
Inventories 18.2 22.0 24.8 22.0 28.4 22.7 21.7 20.8 19.9 19.0
Inventories, % 1.62 3.01 3.06 3.75 3.61 3.01 3.01 3.01 3.01 3.01
Accounts Payable 16.1 17.2 11.9 17.9 26.0 17.5 16.7 16.0 15.3 14.7
Accounts Payable, % 1.43 2.36 1.47 3.05 3.3 2.32 2.32 2.32 2.32 2.32
Capital Expenditure -36.3 -41.0 -17.9 -20.1 -28.0 -27.2 -26.0 -24.9 -23.8 -22.8
Capital Expenditure, % -3.23 -5.63 -2.21 -3.42 -3.56 -3.61 -3.61 -3.61 -3.61 -3.61
Tax Rate, % -9.68 -9.68 -9.68 -9.68 -9.68 -9.68 -9.68 -9.68 -9.68 -9.68
EBITAT 335.1 -358.2 -19.1 -261.5 -276.9 -85.6 -81.9 -78.4 -75.0 -71.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 249.7 -397.9 -11.3 -214.3 -353.0 -59.5 -86.6 -82.8 -79.2 -75.8
WACC, % 5.74 5.89 5.86 5.89 5.89 5.86 5.86 5.86 5.86 5.86
PV UFCF
SUM PV UFCF -323.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -77
Terminal Value -2,006
Present Terminal Value -1,509
Enterprise Value -1,832
Net Debt 1,054
Equity Value -2,887
Diluted Shares Outstanding, MM 143
Equity Value Per Share -20.16

What You Will Get

  • Real IONS Financial Data: Pre-filled with Ionis Pharmaceuticals’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Ionis Pharmaceuticals’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Accurate Ionis Financials: Gain access to reliable pre-loaded historical data and future projections for Ionis Pharmaceuticals, Inc. (IONS).
  • Customizable Forecast Assumptions: Modify highlighted cells such as WACC, growth rates, and profit margins to tailor your analysis.
  • Dynamic Calculations: Enjoy automatic updates to DCF, Net Present Value (NPV), and cash flow assessments.
  • Visual Dashboard: Utilize clear charts and summaries to effectively visualize your valuation outcomes.
  • For Professionals and Beginners: Designed with a user-friendly structure suitable for investors, CFOs, and consultants alike.

How It Works

  • Download: Obtain the pre-built Excel file featuring Ionis Pharmaceuticals' financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and analyze results immediately.
  • Make Decisions: Leverage the valuation insights to inform your investment approach.

Why Choose This Calculator?

  • Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and industry consultants.
  • Accurate Data: Ionis Pharmaceuticals' historical and projected financials preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically calculates intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance to navigate through the calculations.

Who Should Use This Product?

  • Individual Investors: Gain insights to make informed decisions about trading Ionis Pharmaceuticals stock (IONS).
  • Financial Analysts: Enhance valuation accuracy with comprehensive financial models tailored for Ionis Pharmaceuticals.
  • Consultants: Provide clients with expert valuation analysis and insights on Ionis Pharmaceuticals efficiently.
  • Business Owners: Learn how biotech companies like Ionis Pharmaceuticals are valued to inform your own business strategies.
  • Finance Students: Acquire practical valuation skills using real-world data from Ionis Pharmaceuticals.

What the Template Contains

  • Pre-Filled Data: Contains Ionis Pharmaceuticals' historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model featuring automatic calculations.
  • Weighted Average Cost of Capital (WACC): A specialized sheet for calculating WACC based on user-defined inputs.
  • Key Financial Ratios: Evaluate Ionis Pharmaceuticals' profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Easily modify revenue growth rates, profit margins, and tax assumptions.
  • Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.

No products were found matching.